Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Contemp Clin Trials. 2017 Jun 19;60:113–124. doi: 10.1016/j.cct.2017.06.013

Table 1.

Schedule of Evaluations

Study Measure Method Baseline Study Visits Endline Interim Visits1

0 mo 6, 12, 18 mo 24 mo as needed
Demographics Q X
Depressive symptoms
 PHQ-9 Q X X X X
 SCL-20 Q X X X
Other psychiatric conditions
 MoCA; AUDIT-10; DAST-10; Q X X
 GAD-7; Bipolar disease/Psychosis Q X X X
Medical history
 Patient history Q X
 Family history Q X
Medication use Q X X X X
Medical complications Q X X X X
Risk factor control
 SBP/DBP, HR E X X X X
 FBG L X X X X
 HbA1c L X X X X
 Lipids (TC, HDL, LDL, TG) L X X X X
Lifestyle habits: PA, alcohol and tobacco use Q X X X X
Anthropometry: height, weight, BMI, WC E X X X X
Clinical examinations:
 Physical, eye, and foot inspections E X X X X
 Electrocardiogram E X X X X
 Microalbuminuria (UACR) L X X
 Serum creatinine, Na+; K+; ALT L X X X
Patient self-efficacy: SDSCA Q X X X
Quality of life, health utility, satisfaction
 HUI-3 Q X X
 DTSQ Q X X
Costs of care: direct, indirect Q, R X X
SAEs/AEs Q X X X

Abbreviations: PHQ-9, Patient Health Questionnaire-9; SCL-20, Symptom Checklist-20; MoCA, Montreal Cognitive Assessment; AUDIT-10, Alcohol Use Identification Test-10; DAST-10, Drug Abuse Screening Test-10; GAD-7, Generalized Anxiety Disorder-7; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; HR, Heart Rate; FBG, Fasting Blood Glucose; HbA1C, Hemoglobin A1C; TC, Total Cholesterol; HDL, High Density Lipoprotein; LDL, Low Density Lipoprotein; TG, Triglycerides; BMI, Body Mass Index; WC, waist circumference; UACR, Urine Albumin Creatinine Ratio; Na+, Sodium; K+, Potassium; ALT, Alanine Aminotransferase; HUI-3, Health Utilities Index-3; DTSQ, Diabetes Treatment Satisfaction Questionnaire; SDSCA, Summary of Diabetes Self-Care Activities; SAEs, Severe Adverse Events; AEs, Adverse Events; Q, Questionnaire; E, Examination; L, Laboratory test; R, Records.

1

Interim visits measures are collected from participants in the intervention arm, as needed, at the discretion of the care coordinator. Incidence of medical complications and severe and adverse events were asked at each interim visit.